Oral tumoractivated chemotherapy: a new effective and convenient treatment in oncology
- 32 pages
- 2 hours of reading
An exploration of oral tumouractivated chemotherapy. It is taken from the satellite symposium held at the 23rd ESMO Congress in 1998. Areas discussed include fluoropyrimides, the rational design of new tumouractivated cytotoxic agents, and Xeloda in the treatment of metastatic breast cancer.
